Balance Sheet Vimian Group AB

Stocks

VIMIAN

SE0015961982

Pharmaceuticals

Real-time Estimate Cboe Europe Other stock markets 07:21:37 16/07/2026 pm IST			5-day change	1st Jan Change
32.35 ^SEK	+2.70%		+6.25%	+6.46%

03:54pm	Vimian expected to post €28.5m in adjusted EBITA, Modular Finance	FW
10/07	Affarsvarlden issues a buy recommendation for Vimian	FW

5f4b6fec59fef17b29e.kma0i_jhZvETTNbPP5Hk3qDG0Kn3gNNksESQPBQbfR0.1g_n4raPS6VwPoyaduODuNG8tPO-9Zgo9TTWakR4L27AAMX5l7tfmFwCjw

Published financial data: VIMIAN GROUP AB

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	17Cr	28Cr	33Cr	37Cr	42Cr
Other Revenues, Total	-	-	-	-	1L
Total Revenues	17Cr	28Cr	33Cr	37Cr	43Cr
Cost of Goods Sold, Total	5.05Cr	8.73Cr	10Cr	12Cr	13Cr
Gross Profit	12Cr	19Cr	23Cr	26Cr	29Cr
Selling General & Admin Expenses, Total	8.44Cr	13Cr	15Cr	17Cr	19Cr
Depreciation & Amortization - (IS)	1.67Cr	2.72Cr	3.2Cr	3.37Cr	3.79Cr
Other Operating Expenses	-39.78L	-64.1L	2L	11L	-24L
Other Operating Expenses, Total	9.71Cr	15Cr	19Cr	21Cr	23Cr
Operating Income	2.57Cr	4.52Cr	4.33Cr	4.94Cr	6.78Cr
Interest Expense, Total	-67.17L	-1.11Cr	-1.93Cr	-2.53Cr	-2.07Cr
Interest And Investment Income	25T	21T	5L	20L	12L
Net Interest Expenses	-66.92L	-1.1Cr	-1.87Cr	-2.33Cr	-1.95Cr
Income (Loss) On Equity Invest.	99T	-92T	-9L	-	-3L
Currency Exchange Gains (Loss)	-15.55L	-60.79L	-36.19L	17L	38L
Other Non Operating Income (Expenses)	0	1T	3T	0	-8L
EBT, Excl. Unusual Items	1.76Cr	2.8Cr	2.01Cr	2.78Cr	5.1Cr
Merger & Related Restructuring Charges	-38.52L	-55.48L	-16.6L	-	-3L
Gain (Loss) On Sale Of Assets	-15T	-35T	-3L	-1L	-3L
Other Unusual Items	-10L	-2.15Cr	13.22L	11L	-45L
EBT, Incl. Unusual Items	1.28Cr	9L	1.94Cr	2.88Cr	4.59Cr
Income Tax Expense	50L	81.22L	89.63L	95L	1.35Cr
Earnings From Continuing Operations	77.59L	-71.98L	1.05Cr	1.93Cr	3.24Cr
Net Income to Company	77.59L	-71.98L	1.05Cr	1.93Cr	3.24Cr
Minority Interest	-11.73L	5L	-6L	-8L	-11L
Net Income - (IS)	65.86L	-67.42L	98.4L	1.85Cr	3.13Cr
Net Income to Common Incl Extra Items	65.86L	-67.42L	98.4L	1.85Cr	3.13Cr
Net Income to Common Excl. Extra Items	65.86L	-67.42L	98.4L	1.85Cr	3.13Cr
Per Share Items
Net EPS - Basic	0.02	-0.02	0.02	0.04	0.06
Basic EPS - Continuing Operations	0.02	-0.02	0.02	0.04	0.06
Basic Weighted Average Shares Outstanding	35Cr	40Cr	45Cr	50Cr	53Cr
Net EPS - Diluted	0.02	-0.02	0.02	0.04	0.06
Diluted EPS - Continuing Operations	0.02	-0.02	0.02	0.04	0.06
Diluted Weighted Average Shares Outstanding	35Cr	40Cr	45Cr	50Cr	53Cr
Normalized Basic EPS	0.03	0.04	0.03	0.03	0.06
Normalized Diluted EPS	0.03	0.04	0.03	0.03	0.06
Supplemental Items
EBITDA	3.99Cr	6.89Cr	6.92Cr	7.9Cr	9.82Cr
EBITA	3.77Cr	6.53Cr	6.5Cr	7.34Cr	9.27Cr
EBIT	2.57Cr	4.52Cr	4.33Cr	4.94Cr	6.78Cr
Total Revenues (As Reported)	-	-	-	37Cr	43Cr
Effective Tax Rate - (Ratio)	39.19	879	46.09	32.99	29.41
Total Current Taxes	85.23L	1.16Cr	1.22Cr	1.19Cr	2.1Cr
Total Deferred Taxes	-35.23L	-35L	-32.44L	-24L	-75L
Normalized Net Income	98.12L	1.8Cr	1.19Cr	1.66Cr	3.08Cr
Interest on Long-Term Debt	2L	7L	4L	4L	5L
Non-Cash Pension Expense	8T	10T	1T	2T	0
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	-	83.55L	56.71L	37L	51L

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	5.51Cr	4.22Cr	3.75Cr	6.48Cr	5.5Cr
Total Cash And Short Term Investments	5.51Cr	4.22Cr	3.75Cr	6.48Cr	5.5Cr
Accounts Receivable, Total	3.1Cr	4.12Cr	4.61Cr	5.52Cr	5.73Cr
Other Receivables	81.41L	6.05Cr	1.14Cr	1.8Cr	1.52Cr
Total Receivables	3.91Cr	10Cr	5.75Cr	7.32Cr	7.25Cr
Inventory	3.3Cr	6.12Cr	6.03Cr	7.84Cr	8.01Cr
Prepaid Expenses	42.6L	16.21L	36.22L	62L	59L
Other Current Assets, Total	-	1T	1T	1L	-
Total Current Assets	13Cr	21Cr	16Cr	22Cr	21Cr
Gross Property Plant And Equipment	2.99Cr	4.15Cr	4.68Cr	6.9Cr	7.42Cr
Accumulated Depreciation	-35.34L	-66.9L	-1.11Cr	-2.3Cr	-2.78Cr
Net Property Plant And Equipment	2.64Cr	3.48Cr	3.57Cr	4.6Cr	4.64Cr
Long-term Investments	17.97L	1.17Cr	5.76Cr	3.72Cr	1.56Cr
Goodwill	33Cr	46Cr	51Cr	58Cr	59Cr
Other Intangibles, Total	15Cr	20Cr	21Cr	23Cr	24Cr
Deferred Tax Assets Long-Term	20.82L	19.76L	23.96L	10L	52L
Other Long-Term Assets, Total	2T	-2T	-	1L	1L
Total Assets	64Cr	92Cr	97Cr	110.98Cr	110.98Cr
Liabilities
Accounts Payable, Total	1.33Cr	1.83Cr	1.97Cr	2.18Cr	2.01Cr
Accrued Expenses, Total	1.37Cr	2.1Cr	1.06Cr	1.74Cr	1.83Cr
Current Portion of Long-Term Debt	75.78L	-	27T	-	-
Current Portion of Leases	24.06L	48.16L	34.63L	47L	51L
Current Income Taxes Payable	78.75L	81.79L	80.5L	69L	1.03Cr
Unearned Revenue Current, Total	3L	4L	49.96L	7L	9L
Other Current Liabilities	2.76Cr	11Cr	2.8Cr	5.84Cr	5.47Cr
Total Current Liabilities	7.27Cr	17Cr	7.49Cr	11Cr	11Cr
Long-Term Debt	16Cr	21Cr	30Cr	22Cr	22Cr
Long-Term Leases	72.73L	90.29L	82.69L	1.3Cr	1.03Cr
Deferred Tax Liability Non Current	1.75Cr	2.44Cr	2.74Cr	2.94Cr	3.55Cr
Other Non Current Liabilities	2.15Cr	3.53Cr	3.44Cr	3.51Cr	2.25Cr
Total Liabilities	28Cr	44Cr	45Cr	40Cr	40Cr
Common Stock, Total	64T	72T	74T	1L	1L
Additional Paid In Capital	29Cr	43Cr	47Cr	61Cr	63Cr
Retained Earnings	6Cr	5.32Cr	6.31Cr	8.15Cr	11Cr
Comprehensive Income and Other	24.07L	-44.6L	-46.35L	35L	-3.65Cr
Total Common Equity	36Cr	48Cr	53Cr	70Cr	70Cr
Minority Interest	12.26L	-3L	3L	66L	99L
Total Equity	36Cr	48Cr	53Cr	71Cr	71Cr
Total Liabilities And Equity	64Cr	92Cr	97Cr	110.98Cr	110.98Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	39Cr	44Cr	52Cr	52Cr	53Cr
ECS Total Common Shares Outstanding	39Cr	44Cr	46Cr	52Cr	53Cr
Book Value / Share	0.92	1.11	1.15	1.34	1.32
Tangible Book Value	-12Cr	-19Cr	-19Cr	-10Cr	-13Cr
Tangible Book Value Per Share	-0.31	-0.43	-0.42	-0.2	-0.25
Total Debt	18Cr	22Cr	31Cr	23Cr	24Cr
Net Debt	13Cr	18Cr	28Cr	17Cr	18Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	2L	-78T	79T	81T	0
Minority Interest, Total (Incl. Fin. Div)	12.26L	-3L	3L	66L	99L
Equity Method Investments, Total	5L	75.78L	80.3L	91L	1.41Cr
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Raw Materials, Total	16.64L	59.1L	79.92L	2.43Cr	2.27Cr
Inventories - Work In Process, Total	31.08L	45.84L	49.5L	56L	66L
Inventories - Finished Goods, Total	2.82Cr	5Cr	4.73Cr	4.85Cr	5.08Cr
Inventories - Others	18T	7L	-	-	-
Land - (BS)	83.02L	1.04Cr	1.3Cr	1.55Cr	1.51Cr
Machinery, Total	1.15Cr	1.67Cr	1.76Cr	2.83Cr	3.38Cr
Full Time Employees	600	900	1.1T	1.2T	1.02T
Part Time Employees	-	-	-	-	16

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	65.86L	-67.42L	98.4L	1.85Cr	3.13Cr
Depreciation & Amortization - CF	41.77L	70.17L	80.53L	95L	1.05Cr
Amortization of Goodwill and Intangible Assets - (CF)	1.2Cr	2Cr	2.17Cr	2.4Cr	2.49Cr
Depreciation & Amortization, Total	1.62Cr	2.7Cr	2.98Cr	3.35Cr	3.54Cr
Amortization of Deferred Charges, Total - (CF)	5L	2L	22.46L	13L	26L
Other Operating Activities, Total	25.89L	3.15Cr	84.12L	67L	1.99Cr
Change In Accounts Receivable	-55.62L	-37.58L	-82.48L	-92L	2.09Cr
Change In Inventories	-42.59L	-1.98Cr	5L	-3L	-67L
Change in Other Net Operating Assets	-28T	-31.3L	-7.12Cr	76L	23L
Cash from Operations	1.6Cr	2.53Cr	-2.86Cr	5.81Cr	11Cr
Capital Expenditure	-54.07L	-58.22L	-79.26L	-63L	-91L
Sale of Property, Plant, and Equipment	-	-	23T	1L	1L
Cash Acquisitions	-10Cr	-17Cr	-6.16Cr	-8.13Cr	-9.22Cr
Sale (Purchase) of Intangible assets	-60.85L	-44.86L	-69.79L	-79L	-60L
Investment in Marketable and Equity Securities, Total	-11.75L	-69.64L	-12.12L	1.95Cr	-55L
Other Investing Activities, Total	1L	-	-	-1L	-1L
Cash from Investing	-11Cr	-19Cr	-7.77Cr	-7.6Cr	-11Cr
Long-Term Debt Issued, Total	18Cr	15Cr	16Cr	8.04Cr	28Cr
Total Debt Issued	18Cr	15Cr	16Cr	8.04Cr	28Cr
Long-Term Debt Repaid, Total	-10Cr	-14Cr	-6.46Cr	-18Cr	-29Cr
Total Debt Repaid	-10Cr	-14Cr	-6.46Cr	-18Cr	-29Cr
Issuance of Common Stock	5.13Cr	14Cr	4L	14Cr	1.05Cr
Other Financing Activities, Total	14.65L	-16.19L	-44T	-17L	-5L
Cash from Financing	12Cr	15Cr	10Cr	4.48Cr	-12L
Foreign Exchange Rate Adjustments	5L	70T	10.14L	2L	-15L
Miscellaneous Cash Flow Adjustments	-	1T	-	2L	-
Net Change in Cash	2.55Cr	-1.29Cr	-46.94L	2.73Cr	-98L
Supplemental Items
Cash Interest Paid	84.63L	1.04Cr	1.89Cr	2.04Cr	1.57Cr
Cash Income Tax Paid (Refund)	58.78L	76.77L	94.01L	1.51Cr	1.74Cr
Levered Free Cash Flow	-19.68L	4.89Cr	-1.48Cr	3.3Cr	5.08Cr
Unlevered Free Cash Flow	22.3L	5.58Cr	-27.8L	4.88Cr	6.38Cr
Change In Net Working Capital	1.9Cr	-1.06Cr	4.7Cr	27L	15L
Net Debt Issued / Repaid	7.12Cr	1.22Cr	10Cr	-9.62Cr	-1.12Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	2.95	3.61	2.85	2.96	3.82
Return on Total Capital	3.58	4.55	3.51	3.47	4.49
Return On Equity %	2.45	-1.71	2.08	3.13	4.58
Return on Common Equity	2.27	-1.61	1.95	3.02	4.48
Margin Analysis
Gross Profit Margin %	70.87	68.96	69.16	68.92	68.9
SG&A Margin	48.7	45.48	46.4	46.45	44.6
EBITDA Margin %	23.04	24.5	20.86	21.08	23.1
EBITA Margin %	21.76	23.2	19.61	19.58	21.81
EBIT Margin %	14.84	16.08	13.06	13.18	15.95
Income From Continuing Operations Margin %	4.48	-2.56	3.16	5.15	7.62
Net Income Margin %	3.8	-2.4	2.97	4.94	7.36
Net Avail. For Common Margin %	3.8	-2.4	2.97	4.94	7.36
Normalized Net Income Margin	5.66	6.39	3.59	4.42	7.24
Levered Free Cash Flow Margin	-1.14	17.38	-4.47	8.79	11.96
Unlevered Free Cash Flow Margin	1.29	19.83	-0.84	13.01	15
Asset Turnover
Asset Turnover	0.32	0.36	0.35	0.36	0.38
Fixed Assets Turnover	8.03	9.18	9.41	9.19	9.2
Receivables Turnover (Average Receivables)	6.51	7.8	7.6	7.4	7.56
Inventory Turnover (Average Inventory)	1.79	1.85	1.68	1.68	1.67
Short Term Liquidity
Current Ratio	1.81	1.24	2.12	2.03	1.95
Quick Ratio	1.3	0.87	1.27	1.26	1.17
Operating Cash Flow to Current Liabilities	0.22	0.15	-0.38	0.53	0.97
Days Sales Outstanding (Average Receivables)	56.08	46.79	48.02	49.46	48.31
Days Outstanding Inventory (Average Inventory)	204.4	196.88	216.73	217.87	218.81
Average Days Payable Outstanding	73.5	49.94	68.53	56.42	57.11
Cash Conversion Cycle (Average Days)	186.98	193.74	196.22	210.91	210.01
Long Term Solvency
Total Debt/Equity	50.29	45.89	59.58	33.06	33.68
Total Debt / Total Capital	33.46	31.46	37.33	24.85	25.19
LT Debt/Equity	47.51	44.89	58.91	32.4	32.96
Long-Term Debt / Total Capital	31.61	30.77	36.92	24.35	24.65
Total Liabilities / Total Assets	44.03	47.86	45.91	36.34	36.13
EBIT / Interest Expense	3.83	4.09	2.25	1.95	3.28
EBITDA / Interest Expense	6.24	6.54	3.8	3.28	4.99
(EBITDA - Capex) / Interest Expense	5.43	6.01	3.38	3.03	4.55
Total Debt / EBITDA	4.31	3.06	4.29	2.82	2.31
Net Debt / EBITDA	2.99	2.47	3.78	2.04	1.78
Total Debt / (EBITDA - Capex)	4.94	3.33	4.82	3.05	2.54
Net Debt / (EBITDA - Capex)	3.43	2.69	4.24	2.2	1.95
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	143.37	62.28	17.92	12.99	13.42
Gross Profit, 1 Yr. Growth %	164.25	57.91	18.26	12.6	13.4
EBITDA, 1 Yr. Growth %	144.57	72.54	0.39	13.83	19.32
EBITA, 1 Yr. Growth %	144.77	73.02	-0.32	12.58	21.18
EBIT, 1 Yr. Growth %	147.35	75.86	-4.26	13.82	29.14
Earnings From Cont. Operations, 1 Yr. Growth %	-85.17	-192.77	-245.65	85.58	67.88
Net Income, 1 Yr. Growth %	-87.53	-202.37	-245.95	88.78	69.19
Normalized Net Income, 1 Yr. Growth %	-74.19	83.24	-33.83	38.56	55.23
Diluted EPS Before Extra, 1 Yr. Growth %	-89.31	-206.28	-200	83.6	62.15
Accounts Receivable, 1 Yr. Growth %	38.76	32.97	12.02	19.74	3.8
Inventory, 1 Yr. Growth %	40.03	85.48	-1.49	30.02	2.17
Net Property, Plant and Equip., 1 Yr. Growth %	57.48	31.93	2.32	29.21	0.87
Total Assets, 1 Yr. Growth %	43.16	44.14	5.43	13.98	0
Tangible Book Value, 1 Yr. Growth %	-0.41	53.49	3.32	-46.6	26.43
Common Equity, 1 Yr. Growth %	59.55	34.81	9.25	32.96	-0.14
Cash From Operations, 1 Yr. Growth %	233.56	58.07	-212.89	-303.15	81.93
Capital Expenditures, 1 Yr. Growth %	30.04	7.68	36.14	-20.25	44.44
Levered Free Cash Flow, 1 Yr. Growth %	-1.39T	-2.59T	-130.31	-324.55	45.67
Unlevered Free Cash Flow, 1 Yr. Growth %	25.95	2.4T	-104.98	-1.96T	25.76
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	165.83	98.73	38.33	15.43	13.21
Gross Profit, 2 Yr. CAGR %	171.51	104.27	36.66	15.39	13
EBITDA, 2 Yr. CAGR %	189.55	105.42	31.61	7.07	18.95
EBITA, 2 Yr. CAGR %	198.88	105.79	31.33	6.06	19.24
EBIT, 2 Yr. CAGR %	228.14	108.56	29.76	4.5	24.99
Earnings From Cont. Operations, 2 Yr. CAGR %	151.47	-62.91	16.24	63.75	76.5
Net Income, 2 Yr. CAGR %	129.08	-64.26	22.23	65.65	78.71
Normalized Net Income, 2 Yr. CAGR %	176.65	-31.23	10.11	-3.98	60.39
Diluted EPS Before Extra, 2 Yr. CAGR %	112.06	-66.3	3.09	35.5	72.54
Accounts Receivable, 2 Yr. CAGR %	147.68	35.83	22.04	15.79	11.49
Inventory, 2 Yr. CAGR %	183.44	61.16	35.17	13.18	15.25
Net Property, Plant and Equip., 2 Yr. CAGR %	149.38	44.14	16.19	14.9	14.17
Total Assets, 2 Yr. CAGR %	154.27	43.65	23.28	9.62	6.76
Tangible Book Value, 2 Yr. CAGR %	186.12	23.64	25.94	-25.73	-17.83
Common Equity, 2 Yr. CAGR %	195.56	46.65	21.36	20.53	15.23
Cash From Operations, 2 Yr. CAGR %	221.64	129.62	33.58	51.5	92.24
Capital Expenditures, 2 Yr. CAGR %	230.5	18.33	21.07	4.02	7.33
Levered Free Cash Flow, 2 Yr. CAGR %	-63.72	1.69T	174.46	-17.88	86.1
Unlevered Free Cash Flow, 2 Yr. CAGR %	-61.7	461.24	11.62	-6.49	393.65
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	177.6	125.5	67	29.31	14.75
Gross Profit, 3 Yr. CAGR %	187.36	126.64	70.25	28.11	14.72
EBITDA, 3 Yr. CAGR %	249.2	143.66	61.81	25.53	12.53
EBITA, 3 Yr. CAGR %	257.13	149.09	61.62	24.85	12.42
EBIT, 3 Yr. CAGR %	316.12	166.54	60.89	24.3	14.44
Earnings From Cont. Operations, 3 Yr. CAGR %	114.15	80.35	-41.48	35.49	65.11
Net Income, 3 Yr. CAGR %	102.77	75.14	-42.88	41.1	66.82
Normalized Net Income, 3 Yr. CAGR %	221.14	141.15	-32.11	19.1	19.62
Diluted EPS Before Extra, 3 Yr. CAGR %	92.6	68.44	-51.57	24.96	43.85
Accounts Receivable, 3 Yr. CAGR %	145.83	101.3	27.38	21.26	11.65
Inventory, 3 Yr. CAGR %	153.85	146.08	36.77	33.44	9.39
Net Property, Plant and Equip., 3 Yr. CAGR %	152.48	101.69	28.58	20.31	10.02
Total Assets, 3 Yr. CAGR %	168.13	110.44	29.58	20.1	6.31
Tangible Book Value, 3 Yr. CAGR %	198.53	132.49	16.46	-5.4	-11.32
Common Equity, 3 Yr. CAGR %	165.21	127.51	32.94	25.11	13.2
Cash From Operations, 3 Yr. CAGR %	99.26	153.82	81.23	53.66	61.03
Capital Expenditures, 3 Yr. CAGR %	197.19	127.42	23.99	5.23	16.05
Levered Free Cash Flow, 3 Yr. CAGR %	-	48.41	359.32	155.92	1.32
Unlevered Free Cash Flow, 3 Yr. CAGR %	-	54.24	16.22	179.6	4.56
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	-	-	110.1	72.51	42.94
Gross Profit, 5 Yr. CAGR %	-	-	113.46	73.01	44.5
EBITDA, 5 Yr. CAGR %	-	-	136.35	75.36	43.16
EBITA, 5 Yr. CAGR %	-	-	139.35	77.03	43.17
EBIT, 5 Yr. CAGR %	-	-	161.09	83.27	45.49
Earnings From Cont. Operations, 5 Yr. CAGR %	-	-	67.72	73.52	-9.14
Net Income, 5 Yr. CAGR %	-	-	65.61	71.28	-9.93
Normalized Net Income, 5 Yr. CAGR %	-	-	109.29	66.84	-4.14
Diluted EPS Before Extra, 5 Yr. CAGR %	-	-	50	54.4	-19.5
Accounts Receivable, 5 Yr. CAGR %	-	-	85.78	61.35	20.76
Inventory, 5 Yr. CAGR %	-	-	97.29	80.37	27.73
Net Property, Plant and Equip., 5 Yr. CAGR %	-	-	85.1	61.04	22.57
Total Assets, 5 Yr. CAGR %	-	-	96.5	62.12	19.92
Tangible Book Value, 5 Yr. CAGR %	-	-	111.38	47.29	1.29
Common Equity, 5 Yr. CAGR %	-	-	93.99	76.45	25.55
Cash From Operations, 5 Yr. CAGR %	-	-	69.81	106.48	85.59
Capital Expenditures, 5 Yr. CAGR %	-	-	107.51	66.32	16.96
Levered Free Cash Flow, 5 Yr. CAGR %	-	-	-	17.13	219.43
Unlevered Free Cash Flow, 5 Yr. CAGR %	-	-	-	26.26	104.78